SCHEMBL74145

SCHEMBL74145

CC(C)(C)Cc1cccnc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
HIF1A Q16665 1/20 0.55
CHRNB2 P17787 3/20 0.53
CHRNA4 P43681 3/20 0.53
FDPS P14324 5/20 0.53
BTN3A1 O00481 1/20 0.53
PDE3A Q14432 1/20 0.53
CYP2D6 P10635 2/20 0.52
CHRNA7 P36544 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
SLC6A2 P23975 1/20 0.49
SLC6A4 P31645 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KCNH2 Q12809 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31358573 1.00 CYP1A2 (0.55) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
Ammonia Solution, Strong SCHEMBL27962089 0.98 CHRNB2 (0.57) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL8366344 0.83 CHRNA7 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL7382527 0.83 FDPS (0.54) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL15516269 0.83 CYP1A2 (0.61) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL15941315 0.83 SLC6A2 (0.57) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL2376699 0.83 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL19117642 0.83 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL8362817 0.82 CHRNB2 (0.50) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL13715387 0.82 L3MBTL1 (0.55) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 981 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514477-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE Firmenich SA (CH) 2025-03-05 EP claimed
CN-119486703-A Fragrance composition with lasting fragrance appearance 弗门尼舍有限公司 2025-02-18 CN claimed
WO-2023247599-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE FIRMENICH SA (CH) 2023-12-28 WO claimed
US-20230310288-A1 ANTIMICROBIAL COMPOSITION FIRMENICH SA (CH) 2023-10-05 US claimed
US-11666517-B2 Antimicrobial composition FIRMENICH SA (CH) 2023-06-06 US claimed
US-20230105693-A1 ANTIMICROBIAL COMPOSITIONS FIRMENICH SA (CH) 2023-04-06 US claimed
EP-4106718-A1 ANTIMICROBIAL COMPOSITIONS Firmenich SA (CH) 2022-12-28 EP claimed
CN-114794101-A Antimicrobial compositions 弗门尼舍有限公司 2022-07-29 CN claimed
CN-110022680-B Antimicrobial compositions 弗门尼舍有限公司 2022-04-05 CN claimed
CN-114096235-A Antimicrobial compositions 弗门尼舍有限公司 2022-02-25 CN claimed
CN-110022680-A Antimicrobial compositions 弗门尼舍有限公司 2019-07-16 CN claimed
US-20190201300-A1 ANTIMICROBIAL COMPOSITION FIRMENICH SA (CH) 2019-07-04 US claimed
EP-3493674-A2 ANTIMICROBIAL COMPOSITION Firmenich SA (CH) 2019-06-12 EP claimed
WO-2018024886-A2 ANTIMICROBIAL COMPOSITION FIRMENICH SA (CH) 2018-02-08 WO claimed
EP-0688856-B1 Use of an alkyl substituted pyridine as perfuming ingredient FIRMENICH & CIE (CH) 1999-01-20 EP claimed
US-5569660-A USING 3-(2,2-DIMETHYLPROPYL)PYRIDINE FIRMENICH SA (CH) 1996-10-29 US claimed
EP-0688856-A2 Use of an alkyl substituted pyridine as perfuming ingredient FIRMENICH SA (CH) 1995-12-27 EP claimed
JP-8003581-A None JP disclosed
EP-0688856-A2 Use of an alkyl substituted pyridine as perfuming ingredient FIRMENICH SA (CH) 1995-12-27 EP disclosed
EP-0688856-A2 Use of an alkyl substituted pyridine as perfuming ingredient FIRMENICH SA (CH) 1995-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190201300-A1 ANTIMICROBIAL COMPOSITION NONO, ACMSD, TXLNA CYP1A2 769/4885CYP3A4 289/4885CYP2C9 1624/4885
US-11666517-B2 Antimicrobial composition NONO, ACMSD, TXLNA CYP1A2 769/4885CYP3A4 289/4885CYP2C9 1624/4885
US-20230310288-A1 ANTIMICROBIAL COMPOSITION NONO, ACMSD, TXLNA CYP1A2 769/4885CYP3A4 289/4885CYP2C9 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.